Alan Rosenwasser, MD
- Vice Chairman, Department of Obstetrics and Gynecology, UH Portage Medical Center
- Gynecologic Surgery
- High Risk Obstetrics
- Minimally Invasive Laparoscopic Hysterectomies
Patient Satisfaction Reviews
4.7 out of 5
Patient Comments (12)
Reviewed On 5/1/2020
It was a phone appointment. The DR was very through and explained how things are and what will do going forward.
Reviewed On 3/10/2020
I have the utmost trust in Dr. Rosenwasser
Reviewed On 1/26/2020
[...] Dr. Rosenwaser is a wonderful doctor who takes a personal interest in his patiences.
Reviewed On 1/22/2020
Thanks Dr Rossenwasser & all the staff at the Ravenna office. Always very pleasant & very professional. [...]
Reviewed On 1/12/2020
[...]. love dr Rosenwasser
Reviewed On 12/27/2019
he heard my needs and complied.
Reviewed On 12/24/2019
he's rude and talks to you like you're stupid.
Reviewed On 12/11/2019
[...] overall my experience with Dr. Rossenwauser was excellent.
Reviewed On 11/29/2019
Reviewed On 11/21/2019
Great doctor, great support staff
Reviewed On 10/20/2019
Dr Rosenwasser was wonderful. I will continue using him as my doctor.
Reviewed On 7/30/2019
Absolutely love Dr. Rosenwasser. Always explains things very thoroughly and let's you know the next step to things if there is a next step, tests or appointment followups. He always greets you like you're a friend and makes you feel comfortable in the environment that is usually not very comfortable. I recommend him 100%!
- Obstetrics and Gynecology - American Board of Obstetrics and Gynecology
Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - University Hospitals Of Cleveland (1984 - 1988)
Case Western Reserve University School Of Medicine (1984)
Brown University (1980)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Alan Rosenwasser did not disclose any Outside Relationships with Industry.